Cocrystal Pharma, Inc. Common Stock (COCP) Stock Price

COCPStock

$1.02−4.67%52W

Market Cap$19.65M

P/E—

PEG Ratio—

Div yield—

Beta1.64

COCP Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-43.24%

Price vs S&P 500 (4W)-12.96%

VGM Score43.59

Book Value / Share (Quarterly)$0.08

P/TBV (Annual)1.61x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.58

Price vs S&P 500 (YTD)-7.74%

Gross Margin (TTM)41.18%

Net Profit Margin (TTM)-1655.45%

EPS (TTM)$-0.76

10-Day Avg Trading Volume0.03M

EPS Excl Extra (TTM)$-0.76

EPS (Annual)$-1.80

ROI (Annual)-189.02%

Gross Margin (Annual)21.33%

Net Profit Margin (5Y Avg)-12981.54%

Cash / Share (Quarterly)$0.16

ROA (Last FY)-133.77%

EBITD / Share (TTM)$-0.77

ROE (5Y Avg)-78.39%

Operating Margin (TTM)-1678.79%

Cash Flow / Share (Annual)$-0.60

P/B Ratio18.82x

P/B Ratio (Quarterly)13.87x

Net Income / Employee (Annual)$-1,800,000

EV / Revenue (TTM)52.97x

Net Interest Coverage (TTM)-3883.00x

ROA (TTM)-123.33%

EV / EBITDA (TTM)1747.95x

EPS Incl Extra (Annual)$-1.80

Current Ratio (Annual)3.68x

Quick Ratio (Quarterly)1.14x

3-Month Avg Trading Volume0.06M

52-Week Price Return-4.67%

Revenue / Employee (TTM)$33,000

Tangible BV / Share (Quarterly)$26.76

P/S Ratio (Annual)9.78x

Asset Turnover (Annual)0.04x

52-Week High$2.03

Operating Margin (5Y Avg)-26916.68%

EPS Excl Extra (Annual)$-1.80

CapEx CAGR (5Y)-45.07%

26-Week Price Return-33.33%

Quick Ratio (Annual)3.53x

13-Week Price Return7.37%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)1.24x

Enterprise Value$17.48M

Asset Turnover (TTM)0.05x

Book Value / Share Growth (5Y)-44.72%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-480.10%

Cash / Share (Annual)$0.51

3-Month Return Std Dev55.72%

Net Income / Employee (TTM)$-993,800

ROE (Last FY)-189.02%

Net Interest Coverage (Annual)-89.72x

EPS Basic Excl Extra (Annual)$-1.80

P/FCF (TTM)9.87x

Receivables Turnover (TTM)0.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.76

Receivables Turnover (Annual)0.00x

ROI (TTM)-207.47%

P/S Ratio (TTM)59.54x

Pretax Margin (5Y Avg)-16894.02%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$26.76

Price vs S&P 500 (52W)-20.20%

Year-to-Date Return4.19%

5-Day Price Return-3.77%

EPS Normalized (Annual)$-1.80

ROA (5Y Avg)-64.43%

Net Profit Margin (Annual)-480.10%

Month-to-Date Return-11.30%

Cash Flow / Share (TTM)$-1.95

EBITD / Share (Annual)$-1.79

Operating Margin (Annual)-477.11%

LT Debt / Equity (Annual)0.01x

ROI (5Y Avg)-78.38%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.76

P/TBV (Quarterly)1.61x

P/B Ratio (Annual)2.13x

Inventory Turnover (TTM)4.43x

Pretax Margin (TTM)-1655.45%

Book Value / Share (Annual)$0.46

Price vs S&P 500 (13W)4.68%

Beta1.64x

Revenue / Share (TTM)$0.02

ROE (TTM)-207.47%

52-Week Low$0.76

vGradeD

mGradeB

vgmGradeC

COCP Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 13, 2026	-$0.17	-$0.23	-39.39%(-$0.07)
Q1 2026	May 15, 2026	-$0.15	-$0.17	-13.33%(-$0.02)
Q4 2025	Mar 31, 2026	-$0.17	-$0.17	+2.86%(+$0.01)
Q3 2025	Nov 14, 2025	-$0.21	-$0.19	+11.63%(+$0.02)
Q2 2025	Aug 14, 2025	-$0.30	-$0.20	+33.33%(+$0.10)

COCP Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.14

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
COCPCocrystal Pharma, Inc. Common Stock	D	—	B	59.5x	—	41.2%	—	$1.02
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About Cocrystal Pharma, Inc. Common Stock

Cocrystal Pharma develops novel antiviral therapeutics targeting influenza, hepatitis C, and norovirus using structure-based drug design and proprietary technology platforms. The company leverages Nobel Prize-winning expertise to create first-in-class and best-in-class antiviral drugs. Its lead program, CC-31244, is an oral broad-spectrum replication inhibitor in clinical development.

COCP Insider Transactions

BuyAug 5, 2026
FROST PHILLIP MD ET AL
Beneficial Owner of more than 10% of a Class of Security
Shares: 10,000Value: $9,816
BuyAug 3, 2026
FROST PHILLIP MD ET AL
Beneficial Owner of more than 10% of a Class of Security
Shares: 75,000Value: $70,590

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for August 2026

Companies in Related Industries

MGXMetagenomi Therapeutics, Inc. Common StockBiological Products
EVAXEvaxion A/S American Depositary ShareBiological Products
BKHABlack Hawk Acquisition Corporation Class A Ordinary SharesBiological Products
SCLXScilex Holding Company Common StockBiological Products
ESLAEstrella Immunopharma, Inc. Common StockBiological Products
BIOXBioceres Crop Solutions Corp. Ordinary SharesAgricultural Chemicals
ATYRaTyr Pharma, Inc. Common StockBiological Products
DYAIDyadic International, Inc.Biological Products

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$0.76

High$2.03